Release Date: 10/01/20 14:48 Summary: Change in substantial holding from CBA Price Sensitive: No Download Document 213.49KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%